Gsk GSK
NYSE GSK
$50.17 +2.03 (+4.23%)
As of: Sep 14, 2026 · 1:29 PM EDT

Gsk (GSK) Selling, General & Administrative (2009 - 2026)

Analysis

Gsk (GSK) Selling, General & Administrative (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Asml Holding 618.59 Bn 602.61 Bn 5.90 Bn -
2 Hsbc Holdings 362.53 Bn 362.53 Bn - -
3 General Electric 329.66 Bn 320.31 Bn 6.95 Bn 1.13 Bn
4 Astrazeneca 254.29 Bn 249.00 Bn 12.86 Bn -5.65 Bn
5 Citigroup 227.79 Bn -2,074.51 Bn 24.75 Bn -
6 Bhp 216.08 Bn 197.54 Bn - -
7 Rio Tinto 203.71 Bn 199.33 Bn - -
8 Diageo 197.51 Bn 195.48 Bn - -
9 Unilever 139.19 Bn 132.16 Bn - -
10 Gsk 101.60 Bn 101.60 Bn 15.97 Bn -5.80 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 8, 2026 -5.80 Bn
Jun 30, 2026 -2.95 Bn
Mar 31, 2026 -2.86 Bn
Dec 31, 2025 -12.09 Bn
Sep 30, 2025 -3.02 Bn
Jun 30, 2025 -2.85 Bn
Mar 31, 2025 -2.61 Bn
Dec 31, 2024 -14.14 Bn
Sep 30, 2024 -4.94 Bn
Jun 30, 2024 -3.11 Bn
Mar 31, 2024 -2.65 Bn
Dec 31, 2023 -11.65 Bn
Sep 30, 2023 -2.91 Bn
Jun 30, 2023 -2.84 Bn
Mar 31, 2023 -2.60 Bn
Dec 31, 2022 -9.82 Bn
Sep 30, 2022 -2.42 Bn
Jun 30, 2022 -2.60 Bn
Mar 31, 2022 -2.43 Bn
Dec 31, 2021 -4.31 Bn